These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2517364)

  • 61. Studies on haptoglobin binding to concanavalin A.
    Katnik I
    Biochim Biophys Acta; 1984 Oct; 790(1):8-14. PubMed ID: 6433981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
    Clemmensen I; Petersen LC; Kluft C
    Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Role of lysine binding sites in activation of plasminogen by streptokinase].
    Sokolovskaia LI; Makogonenko EM; Grinenko TV; Cederholm-Williams SA
    Ukr Biokhim Zh (1999); 2003; 75(2):25-32. PubMed ID: 14577167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.
    Lo SK; Ryan TJ; Gilboa N; Lai L; Malik AB
    J Clin Invest; 1989 Sep; 84(3):793-801. PubMed ID: 2569479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation.
    Lenich C; Pannell R; Gurewich V
    Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of ligand binding to kringles 4 and 5 fragments from human plasminogen.
    Novokhatny VV; Matsuka YuV ; Kudinov SA
    Thromb Res; 1989 Feb; 53(3):243-52. PubMed ID: 2497544
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.
    Fleury V; Anglés-Cano E
    Biochemistry; 1991 Jul; 30(30):7630-8. PubMed ID: 1677272
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Further characterization of the binding of plasminogen to heparin: evidence for the involvement of lysine residues.
    Soeda S; Ohki H; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1989 Nov; 999(1):29-35. PubMed ID: 2572276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bovine plasma amine oxidase interactions with concanavalin A in solution and with concanavalin A-Sepharose.
    Ishizaki H; Yasunobu KT
    Biochim Biophys Acta; 1980 Jan; 611(1):27-34. PubMed ID: 7350919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selective plasminogen binding: cysteinyl-lysine-dextran protein interactions.
    Warkentin PH
    Biomaterials; 1998 Oct; 19(19):1753-61. PubMed ID: 9856586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms.
    Takada A; Takada Y
    Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen.
    Wiman B; Wallén P
    Thromb Res; 1977 Feb; 10(2):213-22. PubMed ID: 850907
    [No Abstract]   [Full Text] [Related]  

  • 77. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids.
    Peltz SW; Hardt TA; Mangel WF
    Biochemistry; 1982 May; 21(11):2798-804. PubMed ID: 6212078
    [No Abstract]   [Full Text] [Related]  

  • 78. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of Protein Binding Capability of Surfaces via Host-Guest Interactions: Effects of Localized and Average Ligand Density.
    Shi X; Zhan W; Chen G; Yu Q; Liu Q; Du H; Cao L; Liu X; Yuan L; Chen H
    Langmuir; 2015 Jun; 31(22):6172-8. PubMed ID: 25986051
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ion exchange and affinity chromatography during the purification of human plasminogen on sepharose-L-lysine.
    Silverstein RM
    Thromb Res; 1974 May; 4(5):675-86. PubMed ID: 4209021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.